As of today, no effective medical device exists for the therapy of Heart Failure with preserved Ejection Fraction.
Heart failure is a complex clinical syndrome that results from any structural or functional impairment of ventricular filling or ejection of blood1. It is a serious condition in which the heart is unable to pump enough blood to meet the needs of the body. The typical symptoms of heart failure are breathlessness, swollen limbs and fatigue. Despite improvements in healthcare over the past 20 years, the outlook for patients with heart failure remains poor and survival rates are worse than those with most cancers2.
Heart failure occurs mainly in two forms Heart Failure with reduced Ejection Fraction (HFrEF) and Heart Failure with preserved Ejection Fraction HFpEF).
Heart Failure with reduced Ejection Fraction (HFrEF), accounting for less than 50% of heart failure patients, is characterized by the thinning of the left ventricular walls, decreased systolic function (Ejection Fraction ≤35-40%) and enlarged left ventricular volume1 3. Heart Failure with preserved Ejection Fraction (HFpEF), accounting for more than 50% of heart failure patients, is characterized by concentric hypertrophy and results in normal sized left ventricular cavity with thickened walls and preserved systolic function (Ejection Fraction >40-50%)1 3.
More than 26 million people worldwide are living with heart failure 4,5. Heart failure imposes a huge economic burden, with estimated global overall economic cost of more than $108 billion per annum. Direct costs accounted for ~60% ($65 billion) and indirect costs accounted for ~40% ($43 billion) of the overall spending6. With an aging, rapidly expanding and industrializing global population, this value will continue to rise6.
See references here
The Artract Device
The Artract System is a passive hemodynamic assist device that is implanted percutaneously for the treatment of Heart Failure with preserved Ejection Fraction (HFpEF).
Advantages of the Artract System
Our Management Team
Powered by People
Dr. Wolfgang Götz
FOUNDER AND CHAIRMAN OF THE BOARD
CHIEF FINANCIAL OFFICER
Board of Directors
Dr. Wolfgang Götz
EXECUTIVE CHAIRMAN OF THE BOARD
EXECUTIVE DIRECTOR OF THE BOARD
DIRECTOR OF THE BOARD
Get in Touch
Meeting us at events
We plan to attend the following events and are looking forward to arranging a meeting with you.
ICI 4ALL 2022 Meeting
Tel Aviv, Israel
Artract Medical, Inc.
c/o NewAgeVentures | 521 Fifth Avenue, Floor 17 | New York, NY 10175 | USA